Skip to main content
Dryad

Randomized trial of AKI alerts in hospitalized patients

Data files

Oct 06, 2020 version files 2.23 MB

Abstract

Objective: To determine whether electronic health record (EHR) alerts for Acute Kidney Injury (AKI) would improve patient outcomes of mortality, dialysis and progression of AKI. 

Design: Double-blinded, multicenter, parallel, randomized, controlled trial of an electronic AKI alert versus usual care (no alert). Participants were electronically identified and randomized via a best practice alert build using simple randomization with allocation concealment.

Setting: Six diverse hospitals (four teaching and two non-teaching) ranging from small community hospitals to large tertiary care centers.

Participants: 6,030 adult inpatients with AKI, as defined by the Kidney Disease: Improving Global Outcomes (KDIGO) creatinine criteria.

Interventions: An  EHR-based “pop-up” alert for AKI with an associated AKI order set upon provider opening of the patient’s medical record.

Main Outcome Measures: A composite of AKI progression, receipt of dialysis, or death within 14 days of randomization. Pre-specified secondary outcomes included per-hospital outcome rates and rates of various AKI care practices. 

Results: 6,030 patients were randomized over 22 months. The primary outcome occurred in 653 (21.4%) patients in the alert group and 622 (20.9%) in the usual care group (relative risk 1.02, 95% confidence interval [CI] 0.93 to 1.13, p=0.67). Per-hospital analysis revealed worse outcomes in the two non-teaching hospitals (N=765, 13%), where alerts were associated with a relative risk of the primary outcome of 1.49 (95% CI, 1.12 to 1.98, p=0.006). More deaths (15.6% in the alert group vs. 8.6% in the usual care group) occurred at these centers (p=0.003). Certain AKI care practices were increased in the alert group but did not appear to mediate these outcomes.

Conclusions: Alerts did not reduce rates of our primary outcome among hospitalized patients with AKI.  The overall lack of clinical benefit and signals of harm in non-teaching hospitals should lead to a re-evaluation of existing AKI alerting systems.

Trial Registration:  ClinicalTrials.gov NCT02753751.